Suppr超能文献

类固醇对人肾上腺3β-羟基类固醇脱氢酶活性的抑制作用。

Steroid inhibitory effects upon human adrenal 3 beta-hydroxysteroid dehydrogenase activity.

作者信息

Byrne G C, Perry Y S, Winter J S

出版信息

J Clin Endocrinol Metab. 1986 Feb;62(2):413-8. doi: 10.1210/jcem-62-2-413.

Abstract

The inhibitory effects of varying concentrations of steroids upon 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD) kinetics were studied in human adrenal microsomes. Each enzyme assay was conducted in triplicate at five different concentrations of three substrates (dehydroepiandrosterone, pregnenolone, and 17OH-pregnenolone), using microsomes from at least three donors. Each steroid was screened for possible inhibition at concentrations of 10(-8) and 10(-6) M and then studied in more detail at five different concentrations. The type of inhibition and the inhibition constant (Ki) were determined by analysis of Lineweaver-Burk and Dixon plots, together with replots of the slopes from the Dixon plots. The mean Km (Michaelis-Menten constant) for the three substrates was 0.42 +/- 0.04 (SE) mumol/liter (n = 73). Each steroid tested, including delta 5-3 beta-hydroxysteroids, estrogens, and several delta 4-3-ketosteroids, with the exception of cortisol, caused significant inhibition of 3 beta-HSD activity, and in each case the steroid appeared to behave as a competitive inhibitor. In most cases the Ki value was approximately 10(-7) M. At micromolar concentrations several steroids, notably estrone and estradiol, caused almost total inhibition of adrenal 3 beta-HSD activity. Comparison of the calculated Ki values with available data concerning changes in intra-adrenal steroid concentrations during childhood suggests that these changes would be sufficient to cause a relative decline in 3 beta-HSD activity during adrenarche. Although postnatal circulating steroid concentrations would appear to be insufficient to influence adrenal steroidogenesis, the high serum levels of placental steroids during fetal life would be expected to cause marked 3 beta-HSD inhibition.

摘要

在人肾上腺微粒体中研究了不同浓度甾体对3β-羟类固醇脱氢酶/δ5-δ4异构酶(3β-HSD)动力学的抑制作用。使用来自至少三名供体的微粒体,在三种底物(脱氢表雄酮、孕烯醇酮和17-羟孕烯醇酮)的五个不同浓度下,对每种酶测定进行三次重复实验。每种甾体在10^(-8)和10^(-6) M浓度下进行可能抑制的筛选,然后在五个不同浓度下进行更详细的研究。通过分析Lineweaver-Burk和Dixon图以及Dixon图斜率的重新绘制来确定抑制类型和抑制常数(Ki)。三种底物的平均Km(米氏常数)为0.42±0.04(标准误)μmol/升(n = 73)。除皮质醇外,所测试的每种甾体,包括δ5-3β-羟类固醇、雌激素和几种δ4-3-酮类固醇,均对3β-HSD活性产生显著抑制,并且在每种情况下该甾体似乎表现为竞争性抑制剂。在大多数情况下,Ki值约为10^(-7) M。在微摩尔浓度下,几种甾体,特别是雌酮和雌二醇,几乎完全抑制肾上腺3β-HSD活性。将计算出的Ki值与有关儿童期肾上腺内甾体浓度变化的现有数据进行比较表明,这些变化足以导致肾上腺初现期间3β-HSD活性相对下降。虽然出生后循环甾体浓度似乎不足以影响肾上腺类固醇生成,但胎儿期胎盘甾体的高血清水平预计会导致明显的3β-HSD抑制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验